Stephen Scheve’s emphasis over the past 35 years has been in the pharmaceutical and chemical industries, but he has parachuted as trial counsel into an array of significant disputes in other industries. Steve has defended and tried cases throughout the country and has acted as national coordinating counsel for clients in five litigations, each involving lawsuits in more than 30 states.
In addition to his trial work, he has argued appeals on issues of importance to manufacturers in multiple appellate courts. He has handled/supervised more than 1000 cases and, prior to joining Reed Smith, was the designated trial lawyer for a major tobacco manufacturer in smoking and health cases in Texas, Mississippi, Alabama, Arkansas, Oklahoma and New Mexico.
Steve is a highly experienced trial lawyer who has handled numerous commercial disputes for clients involving patents, royalty, supply, license, co-promotion, development and interference settlement agreements. These disputes have included several arbitrations, with controversies involving as much as $1 billion.
In each of the past 16 years, Steve has been identified by the International Who’s Who of Business Lawyers as one of the “best.” In each of the past seven years, Steve has been identified by the International Who’s Who of Life Sciences Lawyers.
- University of Kansas School of Law, 1981, J.D., Order of the Coif; Member, Kansas Law Review
- University of Kansas, 1978, B.S., Journalism
Professional Admissions & Qualifications :
Court Admissions :
- U.S. Supreme Court
- U.S. Court of Appeals – Fifth Circuit
- U.S. District Court – Eastern District of Texas
- U.S. District Court – Northern District of Texas
- U.S. District Court – Eastern District of Missouri
- U.S. District Court – District of Colorado
- Litigation in hundreds of cases involving oilfield steel products, lead paint, organophosphates, tobacco products, prescription and O-T-C drug products and medical devices.
- McMahon v. Eli Lilly and Company, N.D. Illinois (1984) Directed verdict in DES trial involving claim of adenosis and other noncancerous injuries to reproductive tract of DES daughter.
- Bogorad v. Eli Lilly and Company, E.D. Michigan (1986) Directed verdict in DES case involving claim of adenosis and other noncancerous injuries to reproductive tract of DES daughter.
- Harley v. The Upjohn Company, Bexar County, Texas (1992) Defense verdict after two previous mistrials; claims of aberrant behavior and personal injury stemming from use of triazolobenzodiazepine sleeping pill (Halcion®).
- Freeman v. The Upjohn Company, Dallas County, Texas (1994) Jury verdict of $200,000 reversed and rendered in favor of defendant in Halcion® case involving claims of aberrant behavior/psychosis after high-dosage use of triazolobenzodiazepine sleeping pill.
- Williams v. The Upjohn Company, S.D. Texas (1996) Defense verdict in Halcion® case involving claims of aberrant behavior stemming from long-term use of triazolobenzodiazepine sleeping pill.
- Elan v. King Pharmaceuticals (2006) Two-week evidentiary hearing before three-judge arbitral panel in New York City involving breach of a license and development agreement; favorable outcome for client with a $50 million award.
Rate : $$$$